Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Materion reports prelim Q4 profit below estimate; shares down (SeekingAlpha) +++ MATERION Aktie -4,17%

ELANCO Aktie

 >ELANCO Aktienkurs 
21 EUR    -0.9%    (Tradegate)
Ask: 21.02 EUR / 960 Stück
Bid: 20.91 EUR / 960 Stück
Tagesumsatz: 620 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ELANCO Aktie über LYNX handeln
>ELANCO Performance
1 Woche: +3,8%
1 Monat: +14,2%
3 Monate: +18,5%
6 Monate: +73,4%
1 Jahr: +87,2%
laufendes Jahr: +12,5%
>ELANCO Aktie
Name:  ELANCO ANIMAL HEALTH.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US28414H1032 / A2N6BH
Symbol/ Ticker:  5EA (Frankfurt) / ELAN (NYSE)
Kürzel:  FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN
Index:  -
Webseite:  https://www.elanco.com/
Profil:  Elanco Animal Health Incorporated is a leading glo..
>Volltext..
Marktkapitalisierung:  10224.54 Mio. EUR
Unternehmenswert:  13226.73 Mio. EUR
Umsatz:  3910.36 Mio. EUR
EBITDA:  775.94 Mio. EUR
Nettogewinn:  30.66 Mio. EUR
Gewinn je Aktie:  0.06 EUR
Schulden:  3427.42 Mio. EUR
Liquide Mittel:  430.13 Mio. EUR
Operativer Cashflow:  535.75 Mio. EUR
Bargeldquote:  0.35
Umsatzwachstum:  -2.2%
Gewinnwachstum:  -83.34%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  ELANCO
Letzte Datenerhebung:  23.01.26
>ELANCO Kennzahlen
Aktien/ Unternehmen:
Aktien: 496.86 Mio. St.
Frei handelbar: 99.08%
Rückkaufquote: -
Mitarbeiter: 9450
Umsatz/Mitarb.: 0.4 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 5.8%
Bewertung:
KGV: 337.55
KGV lG: 26.4
KUV: 2.6
KBV: 1.81
PEG-Ratio: -
EV/EBITDA: 17.05
Rentabilität:
Bruttomarge: 43.32%
Gewinnmarge: 0.78%
Operative Marge: 5.25%
Managementeffizenz:
Gesamtkaprendite: 0.27%
Eigenkaprendite: 0.54%
>ELANCO Peer Group

Es sind 595 Aktien bekannt.
 
22.01.26 - 17:15
Elanco upgraded, Zoetis downgraded at Piper Sandler (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
22.01.26 - 16:51
Piper Sandler upgrades Elanco as co gains traction with veterinary groups (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
22.01.26 - 14:01
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement (PR Newswire)
 
INDIANAPOLIS, Jan. 22, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026. Elanco will also conduct a conference call on that day with the investment community and media to......
13.01.26 - 01:48
Stocks Rise as Credit Card Shares Slip on Trump Rate Cap Talk | The Close 1/12/2026 (Bloomberg)
 
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Former Federal Reserve Governor Betsy Duke, GE HealthCare's Peter Arduini, CFRA's Ken Leon, Zoetis' Kristin Peck, Morgan Stanley's Lauren Hochfelder, Blackrock's Jay Jacobs, Cornell University's Eswar Prasad, PGIM's Cathy Marcus, Elanco Animal Health's Jeff Simmons, Pfizer's Albert Bourla. (Source: Bloomberg)...
13.01.26 - 01:01
Elanco CEO: Gaining Market Share Via ′Major′ Innovations (Bloomberg)
 
Jeff Simmons, Elanco Animal Health CEO, discusses pet-care growth with Katie Greifeld at the JPMorgan Healthcare Conference on “The Close.” He says the company is focused on pets, cattle and poultry. (Source: Bloomberg)...
06.01.26 - 14:03
Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
 
INDIANAPOLIS, Jan. 6, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026. Jeff Simmons, president and CEO, and Bob VanHimbergen, executive vice president and CFO, will......
01.01.26 - 07:18
Elanco Secures USDA Approval For Befrena, Expands Dermatology Portfolio (AFX)
 
WASHINGTON (dpa-AFX) - Elanco Animal Health Inc. (ELAN) announced that the U.S. Department of Agriculture (USDA) has approved Befrena (tirnovetmab), a new anti-IL31 monoclonal antibody injection d......
31.12.25 - 20:33
Elanco gains approval of Befrena for canine dermatitis (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
31.12.25 - 20:03
Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis (PR Newswire)
 
Elanco's second dermatology product approval in less than 18 months in the estimated $1.3 billion U.S. canine dermatology market Befrena has been shown to be effective for treatment of dogs of any age against canine atopic dermatitis and allergic dermatitis for 6 to 8 weeks of treatment,......
18.12.25 - 15:36
Elanco Receives FDA Conditional Approval For Credelio Quattro CA1 To Treat Screwworm In Dogs (AFX)
 
WASHINGTON (dpa-AFX) - Elanco Animal Health Incorporated (ELAN) on Thursday said it has received conditional approval from the U.S. Food and Drug Administration (FDA) for Credelio Quattro CA1 for ......
18.12.25 - 14:45
Elanco′s Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs (PR Newswire)
 
Conditional Approval Marks Elanco's Third New World Screwworm Treatment Option for Companion Animals, Providing Multiple Treatment Solutions Prior to Fly Being Detected in the U.S. FDA's Conditional Approval of Credelio Quattro-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel......
18.12.25 - 14:42
Jim Cramer Praises Elanco Animal Health: ′They′ve Turned That Company Around′ (Benzinga)
 
Cramer talks Elanco, Rocket Lab, Lithium Americas, Daktronics, M&T Bank and Ondas Holdings on the latest edition of Mad Money. read more...
17.12.25 - 15:45
Elanco Announces Investment in U.S. Manufacturing and R&D, Driven by Tax, Tariff and Regulatory Clarity (Accesswire)
 
NORTHAMPTON, MA / ACCESS Newswire / December 17, 2025 / Elanco announced $400 million in continued investment in its U.S. operations, workforce and communities over the next five years. This deepen......
17.12.25 - 05:01
Insiderhandel: Aufsichtsrat kauft Aktien von Elanco Animal Health im Wert von 213000 USD (Insiderkauf)
 
Kurzius, Lawrence Erik - Aufsichtsrat - Tag der Transaktion: 2025-12-12...
16.12.25 - 04:01
Insiderhandel: PRESIDENT, CEO AND DIRECTOR kauft Aktien von Elanco Animal Health im Wert von 478496 USD (Insiderkauf)
 
Simmons, Jeffrey N. - Vorstand - Tag der Transaktion: 2025-12-11...
16.12.25 - 04:01
Insiderhandel: Vorstand kauft Aktien von Elanco Animal Health im Wert von 95985 USD (Insiderkauf)
 
Modi, Rajeev A. - Vorstand - Tag der Transaktion: 2025-12-11...
16.12.25 - 04:01
Insiderhandel: EVP and CFO kauft Aktien von Elanco Animal Health im Wert von 150426 USD (Insiderkauf)
 
Vanhimbergen, Robert M. - Vorstand - Tag der Transaktion: 2025-12-11...
12.12.25 - 19:45
All You Need to Know About Elanco Animal Health (ELAN) Rating Upgrade to Buy (Zacks)
 
Elanco Animal Health (ELAN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....
10.12.25 - 01:18
Elanco CEO: GLP-1s are Driving Animal Protein Use (Bloomberg)
 
Jeff Simmons, CEO of Elanco Animal Health, says the “humanization of pets” is driving growth. He tells Romaine Bostick and Katie Greifeld on “The Close” that Elanco's new medicine, Canilevia Quattro, is taking significant market share and is the fastest blockbuster in the company's history. (Source: Bloomberg)...
09.12.25 - 17:48
Elanco cuts hundreds of jobs targeting up to $250M in savings by 2030 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Glück ist immer nur das, was wir uns wünschen, nicht das, was wir haben. - Horst Wolfram Geißler
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!